AMBALAL SARABHAI ENT L Share Price

₹ 35.33

+₹0.34 (0.97%)
1D
Last updated 02 Nov, 2026, 15:55 IST
NSE: AMBALALSA
|
Pharmaceuticals

AMBALAL SARABHAI ENT L Share Price Today

As of 3 Nov 2026, AMBALAL SARABHAI ENT L share price is ₹35.33. The stock opened at ₹35.40, compared to its previous close of ₹34.99. During today's trading session, AMBALAL SARABHAI ENT L share price moved in the range of ₹34.75 to ₹35.60, with an average price of ₹35.17 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.15 and a high of ₹49.98. On the performance front, AMBALAL SARABHAI ENT L share price has increased by 11.28% over the last six months and is up 0.23% on a year-on-year basis.

₹34.75
0.97% up today
₹35.60
1D LOW
1D HIGH

AMBALAL SARABHAI ENT L Stock Insights

Latest Earning
Op Profit TrendUp by 283.23% YoY
Latest Earning
Net Profit TrendUp by 261.05% YoY
Latest Earning
Revenue TrendUp by 4.76% YoY
Stock Performance
OutperformingBeat Nifty by 5.89 % in last 3 month
AMBALAL SARABHAI ENT L stock performance
Open₹35.40
High₹35.60
Low₹34.75
Prev. close₹34.99
AMBALAL SARABHAI ENT L trading activity
Volume20,500
Average traded price₹34.94
Last traded time03:55:54 02 Nov
Last traded quantity2,000
Circuit
L
H
₹33.57
₹37.09
52-week
L
H
₹30.15
₹49.98
Mkt Cap Cr
268.22
P/E
19.77
P/B
1.69
ROA
4.82%
ROE
11.24%
ROCE
10.51%
Quick Ratio
1.04
EV/EBITDA
12.87

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Ambalal Sarabhai has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Ambalal Sarabhai appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Ambalal Sarabhai earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

AMBALAL SARABHAI ENT L Company Background

ISIN
INE432A01017
Sector Market Cap
₹ 268.22 Cr

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparations (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in the oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Pvt. Ltd., is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments, distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

AMBALAL SARABHAI ENT L Financial Highlights

  • Revenue: AMBALAL SARABHAI ENT L reported revenue of ₹217.44 crore in FY26 vs ₹207.57 crore in FY25. It showed an increase of 4.76% on a yearly basis.
  • Operating Profit: AMBALAL SARABHAI ENT L reported an operating profit of ₹18.51 crore in FY26 vs ₹4.83 crore in FY25. It showed an increase of 283.23% on a year-on-year basis.
  • Net Profit: AMBALAL SARABHAI ENT L reported a net profit of ₹17.80 crore in FY26 vs ₹4.93 crore in FY25. It showed an increase of 261.05% on a yearly basis.

AMBALAL SARABHAI ENT L Quarterly Result Highlights

  • AMBALAL SARABHAI ENT L reported revenue of ₹45.59 crore in Jun 2026, compared with ₹68.10 crore in Mar 2026, representing a decrease of 33.05% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported an operating profit of ₹4.68 crore in Jun 2026, compared with ₹6.25 crore in Mar 2026, representing a decrease of 25.12% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported a profit of ₹3.98 crore in Jun 2026, compared with ₹6.50 crore in Mar 2026, reflecting a decrease of 38.77% on a QoQ basis.
  • The earnings per share (EPS) of AMBALAL SARABHAI ENT L stood at ₹2.32 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
31.36%
FII
0.00%
Other DII
0.01%
Retail and other
68.63%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.34%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

AMBALAL SARABHAI ENT L Investment Returns

1 day
+0.97%
1 week
-0.65%
1 month
-6.76%
1 year
+0.23%
3 years
+0.23%
5 years
+0.23%

AMBALAL SARABHAI ENT L Share Price History

AMBALAL SARABHAI ENT L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹35.40 / ₹35.33
+0.97%
30 Oct 26
₹35.31 / ₹34.99
-0.91%
29 Oct 26
₹34.75 / ₹35.31
-0.62%
28 Oct 26
₹34.89 / ₹35.53
+1.78%
Show more

AMBALAL SARABHAI ENT L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹202.27₹196.19₹173.57₹170.28
Other Income₹15.17₹11.38₹10.37₹12.49
Total Revenue₹217.44₹207.57₹183.95₹182.77
Total Expenses₹198.54₹196.38₹174.58₹166.91
Profit Before Tax₹18.51₹4.83₹6.65₹15.17
Tax₹0.70-₹0.10₹0.97₹3.72
Profit After Tax₹17.80₹4.93₹5.68₹11.45
EPS - Basic₹2.32₹0.64₹0.74₹1.49
EPS - Diluted₹2.32₹0.64₹0.74₹1.49

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹18.51₹4.83₹6.65₹15.17
Income before WC changes₹15.60₹7.03₹11.12₹14.57
Change in Assets₹2.87-₹38.35₹0.42-₹0.96
Change in Liabilities-₹5.55₹16.91₹1.35-₹3.48
Change in WC-₹2.68-₹21.43₹1.77-₹4.43
Cash flow from Operations₹13.40-₹17.62₹8.89₹5.72
Cash flow from Investing-₹10.25₹13.26-₹5.30-₹16.78
Cash flow from Financing-₹1.85-₹1.52-₹2.95₹9.09
Total Cash Flow₹1.30-₹5.88₹0.65-₹1.97
Cash (Start of the year)₹4.89₹10.78₹10.13₹12.10
Cash (End of the year)₹6.19₹4.89₹10.78₹10.13

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹156.10₹153.08₹130.98₹134.80
Current Assets₹125.03₹118.59₹118.54₹110.94
Total Assets₹281.13₹271.68₹249.52₹245.74
Current Liabilities₹98.54₹120.51₹102.32₹102.87
Net Current Asset₹26.49-₹1.92₹16.23₹8.07
Non-Current Liabilities₹24.22₹11.18₹10.78₹11.94
Equity Capital₹158.36₹139.98₹136.42₹130.93
Total Equity & Liabilities₹281.13₹271.68₹249.52₹245.74

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3.94₹4.04₹3.81₹3.71
Other Income₹15.57₹15.29₹7.89₹10.53
Total Revenue₹19.52₹19.33₹11.70₹14.24
Total Expenses₹9.57₹11.81₹10.89₹9.12
Profit Before Tax₹9.95₹8.08₹0.81₹4.34
Tax-₹1.04-₹0.16-₹1.77₹0.23
Profit After Tax₹10.99₹8.24₹2.58₹4.11
EPS - Basic₹1.43₹1.08₹0.34₹0.54
EPS - Diluted₹1.43₹1.08₹0.34₹0.54

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹9.95₹8.08₹0.81₹4.34
Income before WC changes₹0.20-₹6.15-₹3.16-₹1.37
Change in Assets-₹0.42₹2.33-₹1.91₹2.70
Change in Liabilities-₹2.88₹0.38₹1.93₹0.98
Change in WC-₹3.30₹2.71₹0.02₹3.68
Cash flow from Operations-₹0.26-₹4.08-₹3.82₹1.52
Cash flow from Investing-₹3.02₹6.35₹3.48₹0.61
Cash flow from Financing₹3.40-₹2.31₹0.30-₹3.76
Total Cash Flow₹0.11-₹0.04-₹0.04-₹1.63
Cash (Start of the year)₹0.08₹0.13₹0.17₹1.80
Cash (End of the year)₹0.20₹0.08₹0.13₹0.17

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹44.09₹44.30₹44.79₹45.35
Current Assets₹41.71₹38.62₹36.49₹34.40
Total Assets₹85.79₹82.92₹81.28₹79.74
Current Liabilities₹23.14₹34.12₹40.65₹41.49
Net Current Asset₹18.56₹4.50-₹4.16-₹7.09
Non-Current Liabilities₹3.17₹0.30₹0.34₹0.41
Equity Capital₹59.48₹48.49₹40.29₹37.85
Total Equity & Liabilities₹85.79₹82.92₹81.28₹79.74
* All values are in INR Crore
AMBALAL SARABHAI ENT L market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
AMBALAL SARABHAI ENT L technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
36.81
Neutral
ATR (14)
1.57
Neutral
STOCH(9,6)
27.09
Neutral
STOCH RSI (14)
32.94
Neutral
ADX(9)
32.84
Bearish
UO(9)
45.74
Neutral
ROC(12)
-8.93
Bearish
WillR(14)
-78.68
Neutral
Period
Simple value
Exponential vaue
5D
35.26
35.36
10D
36.03
36.03
20D
37.5
37.17
50D
40.31
38.44
100D
37.6
39.89
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

AMBALAL SARABHAI ENT L
Pharmaceuticals
Add Stock
Add Another

AMBALAL SARABHAI ENT L Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

AMBALAL SARABHAI ENT L Share Price FAQs

Please be aware that AMBALAL SARABHAI ENT L stock prices are subject to continuous fluctuations due to various factors.